糖肽位于糖蛋白的中心区域,是糖蛋白和蛋白聚糖中的糖基通过共价键与氨基酸或多肽相连形成的。糖肽有着和糖蛋白相似的生物功能,但与糖蛋白相比,它的分子量较小,且结构也比较简单,从而成为糖蛋白研究的重要模型。
产品编号 | 结构式 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
N875052 |
![]() | N-芴甲氧羰基-O-(2-乙酰氨基-3,4,6-三-O-乙酰基-2-脱氧-α-D-吡喃半乳糖基)-L-丝氨酸, ≥98% N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-serine, ≥98% |
C32H36N2O13 | |
N875053 |
![]() | N-芴甲氧羰基-O-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-α-D-吡喃半乳糖基)-L-苏氨酸, ≥98% N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine, ≥98% |
C33H38N2O13 | |
D991685 |
![]() | 杜拉鲁肽, >98% Dulaglutide(LY2189265), >98% |
C149H221N37O49 | |
N787501 |
![]() | N-[芴甲氧羰基]-O-(2,3,4,6-四-O-乙酰基-ALPHA-D-甘露糖基)-L-丝氨酸, ≥95% N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-[(2-O,3-O,4-O,6-O-tetraacetyl-alpha-D-mannopyranosyl)oxy]-L-alanine, ≥95% |
C32H35NO14 | |
N787500 |
![]() | N-芴甲氧羰基-O-(2,3,4-三-O-乙酰基-ALPHA-L-岩藻糖基)-L-丝氨酸, ≥95% N-(9H-Fluoren-9-ylmethoxycarbonyl)-O-(2-O,3-O,4-O-triacetyl-6-deoxy-alpha-L-galactopyranosyl)-L-serine, ≥95% |
C30H33NO12 | |
F787498 |
![]() | N-[芴甲氧羰基]-O-(2,3,4,6-四-O-乙酰基-ALPHA-D-甘露糖基)-L-苏氨酸, ≥95% Fmoc-L-Thr(alpha-D-Man(Ac)4)-OH, ≥95% |
C33H37NO14 | |
F787495 |
![]() | N-[芴甲氧羰基]-O-(2,3,4,6-四-O-乙酰基-BETA-D-吡喃葡萄糖基)-L-苏氨酸, ≥95% Fmoc-L-Thr(beta-D-Glc(Ac)4)-OH, ≥95% |
C33H37NO14 | |
O787493 |
![]() | O-[4,6-二-O-乙酰基-2-(乙酰氨基)-2-脱氧-3-O-(2,3,4,6-四-O-乙酰基-BETA-D-吡喃半乳糖基)-ALPHA-D-吡喃半乳糖基]-N-[芴甲氧羰基]-L-丝氨酸, ≥95% O-[4,6-Di-O-acetyl-2-(acetylamino)-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-alpha-D-galactopyranosyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine, ≥95% |
C44H52N2O21 | |
F787489 |
![]() | Fmoc-Ser(Me,Ac4Neu5Acα2-6Ac2GalNAcα)-OH, ≥95% Fmoc-Ser(Me,Ac4Neu5Acα2-6Ac2GalNAcα)-OH, ≥95% |
C50H61N3O24 | |
F787487 |
![]() | Fmoc-Ser((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH, ≥95% Fmoc-Ser((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH, ≥95% |
C62H77N3O32 | |
F787485 |
![]() | Fmoc-Ser(Ac4Manα1-2Ac3Manα)-OH, ≥95% Fmoc-Ser(Ac4Manα1-2Ac3Manα)-OH, ≥95% |
C44H51NO22 | |
F787484 |
![]() | Fmoc-Ser(Ac4Manα1-2Ac3Manα1-2Ac3Manα)-OH, ≥95% Fmoc-Ser(Ac4Manα1-2Ac3Manα1-2Ac3Manα)-OH, ≥95% |
C56H67NO30 | |
S787481 |
![]() | Fmoc-Thr(Ac4Galβ1-3Ac2GalNAcα)-OH, ≥95% (2S,3R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-5-acetyloxy-6-(acetyloxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid, ≥95% |
C45H54N2O21 | |
F787480 |
![]() | Fmoc-Thr(Me,Ac4Neu5Acα2-6Ac2GalNAcα)-OH, ≥95% Fmoc-Thr(Me,Ac4Neu5Acα2-6Ac2GalNAcα)-OH, ≥95% |
C51H63N3O24 | |
F787479 |
![]() | Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH, ≥95% Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH, ≥95% |
C63H79N3O32 | |
F787477 |
![]() | Fmoc-Thr(Ac4Manα1-2Ac3Manα)-OH, ≥95% Fmoc-Thr(Ac4Manα1-2Ac3Manα)-OH, ≥95% |
C45H53NO22 | |
F787475 |
![]() | Fmoc-Thr((Ac4Galβ1-3)Ac3GlcNAcβ1-6AcGalNAcα)-OH, ≥95% Fmoc-Thr((Ac4Galβ1-3)Ac3GlcNAcβ1-6AcGalNAcα)-OH, ≥95% |
C57H71N3O28 | |
F787473 |
![]() | Fmoc-Thr(Ac4Manα1-2Ac3Manα1-2Ac3Manα)-OH, ≥95% Fmoc-Thr(Ac4Manα1-2Ac3Manα1-2Ac3Manα)-OH, ≥95% |
C57H69NO30 | |
S867236 |
![]() | 唾液糖肽, ≥95% Sialylglycopeptide, ≥95% |
C112H187N15Na2O70 | |
G862872 |
![]() | Galβ(1-3)GalNAc-α-Thr, ≥97%(HPLC) Galβ(1-3)GalNAc-α-Thr, ≥97%(HPLC) |
C18H32N2O13 |